Iohexol, a leading non-ionic iodinated contrast agent, plays a pivotal role in modern medical imaging. Its widespread use in CT scans, angiography, and other diagnostic procedures makes understanding its market dynamics, including the availability of suppliers, price trends, and purchasing considerations, crucial for healthcare institutions and professionals.

The global market for Iohexol is robust, driven by the increasing demand for advanced diagnostic imaging techniques worldwide. Numerous manufacturers and suppliers contribute to its availability. Key players in the production and distribution of Iohexol are located across major pharmaceutical hubs, with a significant presence in Asia, Europe, and North America. Companies like TNJ Chemical, GE Healthcare (under the brand name Omnipaque), and various other pharmaceutical chemical suppliers are prominent in this space. Information from sources like ChemicalBook and industry reports highlight a large number of global suppliers, indicating a competitive market.

When discussing Iohexol suppliers, it's important to note the varying scales of operation. Some are large multinational pharmaceutical corporations with integrated manufacturing and distribution networks, while others are specialized chemical suppliers focusing on active pharmaceutical ingredients (APIs) and intermediates. For procurement managers, identifying reliable suppliers who can guarantee consistent quality, regulatory compliance, and timely delivery is paramount. Many platforms and databases list available suppliers, often providing contact information for price inquiries and product details, such as minimum order quantities and purity specifications.

The price of Iohexol can fluctuate based on several factors. These include the purity grade of the product (e.g., pharmaceutical grade vs. research grade), the quantity purchased, the specific formulation or concentration, and the prevailing market conditions. Global supply chain dynamics, raw material costs, and regulatory compliance expenses also play a role. Typically, purchasing in larger bulk quantities from established suppliers leads to more favorable pricing. For instance, comparing the price of Iohexol from different manufacturers can reveal significant variations, necessitating thorough market research before making a purchase decision.

For those looking to purchase Iohexol, several considerations are essential. Firstly, ensuring the product meets all relevant pharmacopoeial standards (e.g., USP, EP) is non-negotiable for medical applications. This involves verifying certifications and quality control documentation from the supplier. Secondly, understanding lead times for delivery is critical for inventory management and ensuring availability for patient procedures. Building relationships with multiple trusted suppliers can also mitigate risks associated with supply chain disruptions.

The market for Iohexol is characterized by continuous demand, driven by the expanding use of medical imaging. While the core product remains consistent, innovation in delivery systems and formulations may emerge. For healthcare providers and procurement specialists, staying informed about Iohexol market trends and supplier capabilities ensures access to this vital diagnostic agent for effective patient care.